KYMR Kymera Therapeutics, Inc.

NEUTRAL Impact: 3/10 Institutional Cluster
Horizon weeks Processed 3d 21h ago
Institutional cluster: 4 buyers, 1 sellers (bullish)

Executive Summary

A cluster of four mega-passive institutions (State Street, Morgan Stanley, Wells Fargo, BofA) added a combined $62.8M to their KYMR positions in Q3 2025, while T. Rowe Price trimmed a tiny position. All buying is passive/index-driven, with no active or activist fund participation. Despite the net $62.8M inflow, the purely passive nature of the buying and KYMR's heavy history of negative post-report drift (14% win rate at T+20) suggest the signal lacks genuine conviction.

Key Financial Metrics

Direction
accumulating
Buy Value
$148.0M
Sell Value
$289.0K
Net Flow
$62.8M

Institutional Positions

Net institutional flow: $62.8M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
State Street ADD +29.9% $114.3M $46.5M
Morgan Stanley ADD +59% $21.4M $11.0M
BofA ADD +38% $10.5M $4.7M
Wells Fargo ADD +25.4% $1.8M $699.0K

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
T. Rowe Price TRIM -25.7% $299.0K -$10.8K

Actionable Insight

Monitor for entry of active managers or hedge funds as a stronger conviction signal. The all-passive buying cluster is likely index/completion fund rebalancing, not alpha-seeking conviction. Given KYMR's poor post-report drift track record, treat the cluster as noise unless follow-on 13F filings reveal activist or value-fund accumulators.

Key Facts

  • 4 mega-passive institutions accumulated $62.8M in KYMR during Q3 2025.
  • State Street added the most: +29.9% shares, value increasing $46.5M to $114.3M.
  • No active managers, hedge funds, or family offices participated in the cluster.
  • T. Rowe Price trimmed a minimal position (value drop of ~$10.8K, $289K → $289K).
  • KYMR has a 93% bullish analyst consensus but the stock has historically performed poorly following past reports (14% win rate T+20).

Financial Impact

$62.8M net institutional buying concentrated among passive index funds in Q3 2025.

institutional holdingsfloat percentage

Risk Factors

  • Passive buying may reverse on next index rebalance; no active manager signal to provide support.
  • Historical reports on KYMR have a 14% T+20 win rate with average alpha of -9.46%, suggesting the stock tends to sell off after filing events.
  • No fundamental catalyst provided — the cluster could represent end-of-quarter portfolio alignment rather than a directional thesis.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (30 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-KYMR-2025-Q3
18 reports for KYMR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for KYMR — sortable, filterable
Type Now
Jun 12, 2026
2d ago
Press Release
NEUTRAL ★ 3/10
$82.96 awaiting T+5awaiting T+5
Jun 11, 2026
3d ago
Institutional Cluster
MIXED ★ 4/10
$82.43 awaiting T+5awaiting T+5
Jun 11, 2026
3d ago
Institutional Cluster
NEUTRAL ★ 3/10
$79.19 awaiting T+5awaiting T+5
Jun 8, 2026
6d ago
Press Release
BULLISH ★ 6/10
$73.80 awaiting T+5awaiting T+5
May 26, 2026
19d ago
144
NEUTRAL ★ 2/10
$81.70 $73.21▼ −10.39%▼ −10.86%
May 15, 2026
4w ago
Press Release
NEUTRAL ★ 4/10
$82.21 $78.89▼ −4.04%▼ −5.00%
May 11, 2026
4w ago
144
NEUTRAL ★ 2/10
$83.55 $79.67▼ −4.64%▼ −4.72%
Apr 23, 2026
7w ago
Press Release
NEUTRAL ★ 3/10
$87.17 $81.51▼ −6.49%▼ −7.97%
Apr 15, 2026
8w ago
144
NEUTRAL ★ 3/10
$86.14 $87.17▲ +1.20%▲ +0.21%
Apr 15, 2026
8w ago
144
NEUTRAL ★ 3/10
$86.14 $87.17▲ +1.20%▲ +0.21%
Showing 10 of 18

US Market Status

Market Closed — Opens in 3h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access